MedTrace Logo

Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline

NCT01746303 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2016-05-27

No results posted yet for this study

Summary

The aim of this study is to determine the efficacy of 6 months' dietary supplementation with omega-3 fatty acids and whole freeze dried blueberry powder in improving cognition in older adults. The effects of each of these interventions alone will also be assessed in order to determine whether the combined treatment confers synergistic or additive benefit relative to the effect of each therapy.

Conditions

  • Age-related Memory Disorders
  • Mood Disorders

Interventions

DIETARY_SUPPLEMENT

Omega-3 fatty acid

A fixed dose of 2.4 g/day (EPA: 1.6 g, DHA: 0.8 g; 4 capsules/d).

DIETARY_SUPPLEMENT

Blueberry powder

Whole, freeze-dried blueberry powder made of 50%:50% mixture of Tifblue and Rubel blueberries.

OTHER

Placebo oil

Corn oil capsules that are identical in size, shape, and color to omega-3 capsules.

OTHER

Placebo powder

Placebo powder matched for color, taste, and sugar content as closely as possible and milled similarly to the blueberry powder.

Sponsors & Collaborators

  • University of Cincinnati

    lead OTHER

Principal Investigators

  • Robert Krikorian, PhD · University of Cincinnati

  • Robert McNamara, PhD · University of Cincinnati

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
62 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01746303 on ClinicalTrials.gov